Skip to main content
Log in

Comparative effects of celiprolol, propranolol, oxprenolol, and atenolol on respiratory function in hypertensive patients with chronic obstructive lung disease

  • Hypertension
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Summary

The aim of the study was to compare the pulmonary effects of four beta-blockers with different ancillary properties: propranolol (non-beta1 selective without ISA), oxprenolol (non-beta1 selective with ISA), atenolol (beta1 selective), and celipropol (beta1 selective with mild beta2-agonist and alpha2-antagonist activity) in hypertensive patients with chronic obstructive lung disease. Ten asthmatic patients, all males, aged 50–66 years were studied. Entry criteria were a) DBP≧95 mmHg and ≦115 mmHg; b) FEV1<70% of the theoretical values; c) FEV1 increase of at least 20% after salbutamol inhalation (200 μg). After a 2-week washout period on placebo, each patient received propranolol (80 mg/day), oxprenolol (80 mg/day), atenolol (100 mg/day), and celiprolol (200 mg/day) for 1 week, according to a randomized, cross-over design. At the end of the washout and of each treatment period, airway function, assessed by FEV1, FVC, and FEV1%, was evaluated by spirometry both in the basal condition and after salbutamol inhalation. Unlike propranolol and oxprenolol, which significantly reduced FEV1 and inhibited the bronchdilator response to inhaled salbutamol, atenolol and celiprolol did not significantly affect respiratory function and did not antagonize salbutamol effects. Celiprolol more closely approached placebo in its respiratory effects than did atenolol, although the differences were not statistically significant.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. McNeil RS. Effect of a beta-adrenergic blocking agent, propranolol, on asthmatics.Lancet 1964;2:1101–1102.

    Google Scholar 

  2. McNeil RS, Ingram CG. Effect of propranolol on ventilatory function.Am J Cardiol 1966;18;473–475.

    PubMed  Google Scholar 

  3. Nordstrom LA, MacDonald F, Gobel FL. The effect of propranolol on respiratory function and exercise tolerance in patients with chronic obstructive lung disease.Chest 1975;67:287–292.

    PubMed  Google Scholar 

  4. Zaid G, Beall GN. Bronchial response to beta-adrenergic blockade.N Engl J Med 1966;275:580–584.

    PubMed  Google Scholar 

  5. Dorow P. Einfuhrung. In: Dorow P. Ed.Beta-blockade und atemwegsfunction Pneumologishes Kolloquium, H295, Berlin: Walter de Dryter, 1985:1–10.

    Google Scholar 

  6. McDevitt DG. Beta-adrenoceptor antagonists and respiratory function.Br J Clin Pharmacol 1978;5:97–99.

    PubMed  Google Scholar 

  7. Anderson EG, Calcraft B, Jarawalla AG, Al-Zaiback N. Persistent asthma after treatment with beta blocking drugs.Br J Dis Chest 1979;73:407–408.

    PubMed  Google Scholar 

  8. Raine JM, Palazzo MG, Kerr JH, Sleight P. Near fatal bronchospasm after oral nadolol in a young asthmatic and response to ventilation with halothane.Br Med J 1981; 282;548–549.

    Google Scholar 

  9. Lofdahl CG, Svedmyr N. Cardioselectivity of atenolol and metoprolol. A study in asthmatic patients.Eur J Respir Dis 1981;62:396–404.

    PubMed  Google Scholar 

  10. Lawrence DS, Sahay JN, Chatterjee SS, Cruickshank JM. Beta-blockers and asthma.Drugs 1983;25(Suppl 2):232–236.

    Google Scholar 

  11. Kendall MJ, John VA, Quarterman CP, Welling PG. A single and multiple dose pharmacokinetic and pharmacodynamic comparision of conventional and slow release metoprolol.Eur J Clin Pharmacol 1980;17:87–92.

    PubMed  Google Scholar 

  12. Cruickshank JM. The clinical importance of cardioselectivity and lipophilicity in beta-blockers.Am Heart J 1980;100:160P-178.

    Google Scholar 

  13. Formgren H. The effect of metoprolol and practolol on lung function and blood pressure in hypertensive asthmatics.Br J Clin Pharmacol 1976;3:1007–1011.

    Google Scholar 

  14. Dorow P, Bethge H, Tonnesmann U. Effects of single oral doses of bisoprolol and atenolol on airway function in non-asthmatic chronic obstructive lung disease and angina pectoris.Eur J Clin Pharmacol 1986;31:143–147.

    PubMed  Google Scholar 

  15. Chang LTC. Use of practolol in asthmatic: A plea for caution.Lancet 1971;2:321.

    Google Scholar 

  16. Wall Manning HJ, Simpson FO. Practical treatment in asthmatics.Lancet 1971;2:1264–1205.

    PubMed  Google Scholar 

  17. Decalmer PB, Chatterjee S, Cruickshank JM, et al. Beta-blockers and asthma.Br Heart J 1978;40:184–189.

    PubMed  Google Scholar 

  18. Oh UM, Kaye CM, Warrington SJ, et al. Studies of cardioselectivity and partial agonist activity in beta-adrenoceptor blockade effects on heart rate and peak expiratory flow rate during exercise.Br J Clin Pharmacol 1978;5:107–120.

    PubMed  Google Scholar 

  19. Garrad GS. The effects of conventional and slow-release oxprenolol on airways function, in normal subjects. In: Judd J, ed.Topics in cardiovascular disease. Symposium Basle 1976, Ciba, Horsham England, 1977:157.

    Google Scholar 

  20. Macdonald AG, McNeill RS. A comparison of the effect on airway resistance of a new beta-blocking drug ICI.50,172 and propranolol.Br J Anaesthesia 1968;40:508–510.

    Google Scholar 

  21. Beumer HM. Adverse effects of beta-adrenergic receptor blocking drugs on respiratory function.Drugs 1974;7:13–138.

    Google Scholar 

  22. Paterson JW. Beta-adrenergic blocking drugs.Br Med J 1971;2:652.

    Google Scholar 

  23. Christensen CC, Boye NP. Erikson H, Hansen G. Influence of pindolol (Visken) on respiratory function in 20 asthmatic patients.Eur J Clin Pharmacol 1978;13:9–12.

    PubMed  Google Scholar 

  24. Ruffin RE, McIntyre EL, Latimer KM, et al. Assessment of beta-adrenoceptor antagonists in asthmatic patients.Br J Clin Pharmacol 1982;13:325S-335S.

    PubMed  Google Scholar 

  25. Lammers JW, Folgering M, Van Herwaarden CL. Ventilatory effects of long-term treatment with pindolol and metoprolol in hypertensive patients with chronic obstructive lung disease.Br J Clin Pharmacol 1985;20:205–210.

    PubMed  Google Scholar 

  26. Brown R, Slutsky A, Doshan HD, et al. The effect of celiprolol, a bronchosparing cardioselective beta1-alpha2-adrenoceptor blocking agent in asthma.Circulation 1984;70 (Suppl II):382.

    Google Scholar 

  27. Hitzenberger G. Celiprolol, clinical dosage, efficacy an safety in asthmatic and elderly patients.Br J Clin Pract 1985;29(Suppl 40):25–32.

    Google Scholar 

  28. Matthys H, Pohl M, Braig H, Ruhle KH. The cardiopulmonary effects of celiprolol and propranolol in asymptomatic bronchial asthmatics.Br J Clin Pract 1985;39(Suppl 40):33.

    Google Scholar 

  29. Matthys H, Doshan HD, Ruhle KH, et al. Bronchopsaring properties of celiprolol, a new beta1, alpha2-blocker, in propranolol sensitive asthmatic patients.J Cardidovasc Pharmacol 1986;8(Suppl 40):40–43.

    Google Scholar 

  30. Rosenthal RR, Doshan HD, Applin WJ, Caruso FS. Celiprolol: An investigation of a new beta1-alpha2-adrenoceptor antagonist in asthmatic patients.Br J Clin Pract 1985;39(Suppl 40):34–36.

    Google Scholar 

  31. Capone P, Mayol R. A comparative study of celiprolol and placebo in the treatment of hypertension.Br J Clin Pract 1985;39(Suppl 40):65–69.

    Google Scholar 

  32. Dorow P, Clauzel AM, Capone P, et al. A comparison of celiprolol and chlorthalidone in hypertensive patients with reversible bronchial obstruction.J Cardiovasc Pharmacol 1986;8:102–104.

    Google Scholar 

  33. Bruschi C, Casali L, Cerveri I, et al. effects of celiprolol on the bronchial reactivity in asthma.Am J Cardiol 1988;61:53C-54C.

    PubMed  Google Scholar 

  34. Doshan H, Brown R, Applin WJ, etal. Effects of high doses of celiprolol in asthmatic patients.J Cardiovasc Pharmacol 1986;8(Suppl 4):109–111.

    PubMed  Google Scholar 

  35. Dorow P. Celiprolol—Review of airways studies.Am J Cardiol 1988;61:23C-26C.

    PubMed  Google Scholar 

  36. Doshan HD, Rosenthal RR, Brown R, et al. Celiprolol, atenolol and propranolol: A comparison of pulmonary effects in asthmatic patients.J Cardiovasc Pharmacol 1986;8 (Suppl 4):105–108.

    Google Scholar 

  37. Van Zyl AI, Jennings AA, Bateman ED, Opie LH. Comparison of respiratory effects of two cardioselective betablockers, celiprolol and atenolol, in asthmatics with mild to moderate hypertension.Chest 1989;95;209–213.

    PubMed  Google Scholar 

  38. Van Inwegen RG, Khandwala A, Ingram R, et al. Effects of celiprolol on the interactions of serotonin (5HT) and postsynaptic alpha2-receptors in isolated cat tracheal rings.Fed Proc 1984;43:745.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fogari, R., Zoppi, A., Tettamanti, F. et al. Comparative effects of celiprolol, propranolol, oxprenolol, and atenolol on respiratory function in hypertensive patients with chronic obstructive lung disease. Cardiovasc Drug Ther 4, 1145–1149 (1990). https://doi.org/10.1007/BF01856511

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01856511

Key Words

Navigation